Inhalable Vaccines: Can They Help Control Pandemics?
The emergence of a new coronavirus presents a huge risk to public health worldwide and has spread widely amongst the human population. Since its emergence, the severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2) is frequently evolving by mutation and genetic recombination to give rise to ne...
Main Authors: | Vivek P. Chavda, Lalitkumar K. Vora, Vasso Apostolopoulos |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-08-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/8/1309 |
Similar Items
-
The role of vaccination route with an adenovirus-vectored vaccine in protection, viral control, and transmission in the SARS-CoV-2/K18-hACE2 mouse infection model
by: Alexandria Dickson, et al.
Published: (2023-08-01) -
Is Booster Dose Strategy Sufficient for Omicron Variant of SARS-CoV-2?
by: Vivek P. Chavda, et al.
Published: (2022-02-01) -
Oral and intranasal vaccines against SARS‐CoV‐2: Current progress, prospects, advantages, and challenges
by: Sanchita Kar, et al.
Published: (2022-04-01) -
Replicating Viral Vector-Based Vaccines for COVID-19: Potential Avenue in Vaccination Arena
by: Vivek P. Chavda, et al.
Published: (2022-04-01) -
Immunogenicity and Safety of a Combined Intramuscular/Intranasal Recombinant Spike Protein COVID-19 Vaccine (RCP) in Healthy Adults Aged 18 to 55 Years Old: A Randomized, Double-Blind, Placebo-Controlled, Phase I Trial
by: Masoud Solaymani Dodaran, et al.
Published: (2023-02-01)